What drives poor functioning in the at-risk mental state? A systematic review

被引:90
作者
Cotter, Jack [1 ]
Drake, Richard J. [1 ]
Bucci, Sandra [2 ]
Firth, Joseph [1 ]
Edge, Dawn [1 ,2 ]
Yung, Alison R. [1 ,3 ]
机构
[1] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England
[3] Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic 3010, Australia
关键词
At-risk mental state; Ultra-high risk; Clinical high risk; Psychosis; Functioning; Systematic review; ULTRA-HIGH-RISK; CLINICAL HIGH-RISK; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; TERM-FOLLOW-UP; YOUNG-PEOPLE; NEGATIVE SYMPTOMS; CANNABIS USE; INDICATED PREVENTION;
D O I
10.1016/j.schres.2014.09.012
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Transition to psychotic disorder has been the traditional outcome of interest for research in the at-risk mental state (ARMS). However, there is growing recognition that individuals with ARMS may function poorly regardless of whether they develop psychosis. We aimed to review the literature to determine whether there are specific factors associated with, or predictive of, functional impairment in the ARMS population. Method: An electronic database search of MEDLINE, PsycINFO and Embase from inception until May 2014 was conducted using keyword search terms synonymous with the at-risk mental state and functioning. Eligible studies were original peer-reviewed English language research articles with populations that met validated at-risk diagnostic criteria and examined the cross-sectional or longitudinal association between any variable and a measure of functioning. Results: Seventy-two eligible studies were identified. Negative symptoms and neurocognitive impairment were associated with poor functioning in cross-sectional studies. Negative and disorganised symptoms, neurocognitive deficits and poor functioning at baseline were predictive of poor functional outcome in longitudinal studies. Positive symptoms were unrelated to functioning in both cross-sectional and longitudinal studies. Functional disability was persistent and resistant to current treatments. Conclusions: Negative and disorganised symptoms and cognitive deficits pre-date frank psychotic symptoms and are risk factors for poor functioning. This is consistent with a subgroup of ARMS individuals potentially having neurodevelopmental schizophrenia. Treatments aimed at improving functioning must be considered a priority on par with preventing transition to psychosis in the development of future interventions in the ARMS group. (C) 2014 Elsevier B. V. All rights reserved.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 112 条
  • [1] Early traumatic experiences in those at clinical high risk for psychosis
    Addington, Jean
    Stowkowy, Jacqueline
    Cadenhead, Kristin S.
    Cornblatt, Barbara A.
    McGlashan, Thomas H.
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    Woods, Scott W.
    Cannon, Tyrone D.
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2013, 7 (03) : 300 - 305
  • [2] At Clinical High Risk for Psychosis: Outcome for Nonconverters
    Addington, Jean
    Cornblatt, Barbara A.
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    McGlashan, Thomas H.
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    Woods, Scott W.
    Heinssen, Robert
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (08) : 800 - 805
  • [3] A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis
    Addington, Jean
    Epstein, Irvin
    Liu, Lu
    French, Paul
    Boydell, Katherine M.
    Zipursky, Robert B.
    [J]. SCHIZOPHRENIA RESEARCH, 2011, 125 (01) : 54 - 61
  • [4] Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals
    Amminger, G. P.
    Schaefer, M. R.
    Klier, C. M.
    Slavik, J-M
    Holzer, I.
    Holub, M.
    Goldstone, S.
    Whitford, T. J.
    McGorry, P. D.
    Berk, M.
    [J]. MOLECULAR PSYCHIATRY, 2012, 17 (12) : 1150 - 1152
  • [5] Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial
    Amminger, G. Paul
    Schafer, Miriam R.
    Papageorgiou, Konstantinos
    Klier, Claudia M.
    Cotton, Sue M.
    Harrigan, Susan M.
    Mackinnon, Andrew
    McGorry, Patrick D.
    Berger, Gregor E.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (02) : 146 - 154
  • [6] [Anonymous], SCHIZOPHR RES S2
  • [7] [Anonymous], SCHIZOPHR B IN PRESS
  • [8] Auther A., 2006, Global Functioning: Social Scale (GF: Social)
  • [9] Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome
    Auther, A. M.
    McLaughlin, D.
    Carrion, R. E.
    Nagachandran, P.
    Correll, C. U.
    Cornblatt, B. A.
    [J]. PSYCHOLOGICAL MEDICINE, 2012, 42 (12) : 2485 - 2497
  • [10] Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis
    Barbato, Mariapaola
    Liu, Lu
    Penn, David L.
    Keefe, Richard S. E.
    Perkins, Diana O.
    Woods, Scott W.
    Addington, Jean
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 542 - 546